The BalancedInvestor Club

CDNA Market Analysis

Overview

Fundamentals

P/E ratio—Forward 94.34
EPS (TTM)$-0.160.0% YoY
Profit margin-2.0%HEALTHCARE
Market cap$1.11BSmall cap

Wall Street coverage

$25.80median target· current $10.18 (+153.4%)8 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
94.34
PEG ratio
-0.12
P/B
3.54
P/S (TTM)
2.69
EV/EBITDA
171.37

Profitability & growth

ROE (TTM)
-2.4%
Operating margin
1.5%
Revenue growth YoY
39.0%
Dividend yield
—
Beta
2.49
Last earnings
Mar 31, 2026 · Estimate $0.13 · Reported $0.34
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About CareDx Inc

CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.

Classification

Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
8000 MARINA BOULEVARD, BRISBANE, CA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$1.11B
Shares outstanding$51.7M
52W high$23.24
52W low$10.96

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer